CN1168634A - 用于骨质疏松症疗程的试剂盒 - Google Patents

用于骨质疏松症疗程的试剂盒 Download PDF

Info

Publication number
CN1168634A
CN1168634A CN95196670A CN95196670A CN1168634A CN 1168634 A CN1168634 A CN 1168634A CN 95196670 A CN95196670 A CN 95196670A CN 95196670 A CN95196670 A CN 95196670A CN 1168634 A CN1168634 A CN 1168634A
Authority
CN
China
Prior art keywords
pharmaceutically acceptable
nutritional supplement
acid
calcium
tiludroic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95196670A
Other languages
English (en)
Chinese (zh)
Inventor
M·加萨德
O·格罗斯
J·吉拉德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of CN1168634A publication Critical patent/CN1168634A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN95196670A 1994-12-06 1995-12-05 用于骨质疏松症疗程的试剂盒 Pending CN1168634A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
FR94/14630 1994-12-06

Publications (1)

Publication Number Publication Date
CN1168634A true CN1168634A (zh) 1997-12-24

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95196670A Pending CN1168634A (zh) 1994-12-06 1995-12-05 用于骨质疏松症疗程的试剂盒

Country Status (20)

Country Link
EP (1) EP0797444A1 (enExample)
JP (1) JPH10509729A (enExample)
KR (1) KR980700083A (enExample)
CN (1) CN1168634A (enExample)
AR (1) AR002946A1 (enExample)
AU (1) AU4307396A (enExample)
BR (1) BR9509961A (enExample)
CA (1) CA2207028A1 (enExample)
CZ (1) CZ175397A3 (enExample)
FI (1) FI972383A7 (enExample)
FR (1) FR2727629A1 (enExample)
HU (1) HUT77382A (enExample)
IL (1) IL116168A0 (enExample)
MA (1) MA23737A1 (enExample)
NO (1) NO972558L (enExample)
PL (1) PL320564A1 (enExample)
SK (1) SK68597A3 (enExample)
TR (1) TR199501530A1 (enExample)
WO (1) WO1996017616A1 (enExample)
ZA (1) ZA9510184B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
CA2763775C (en) 2002-05-10 2014-01-07 F. Hoffmann-La Roche Ag Bisphosphonic acids for the treatment and prevention of osteoporosis
RU2315603C2 (ru) * 2002-12-20 2008-01-27 Ф.Хоффманн-Ля Рош Аг Композиция с высокой дозой ибандроната

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
EP0648120B1 (en) * 1992-06-30 1997-12-29 PROCTER & GAMBLE PHARMACEUTICALS, INC. Use of phosphonates for the treatment of osteoporosis
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
FI972383A0 (fi) 1997-06-05
CA2207028A1 (en) 1996-06-13
ZA9510184B (en) 1996-06-11
AU4307396A (en) 1996-06-26
IL116168A0 (en) 1996-01-31
HUT77382A (hu) 1998-04-28
KR980700083A (ko) 1998-03-30
CZ175397A3 (en) 1997-10-15
NO972558L (no) 1997-08-05
PL320564A1 (en) 1997-10-13
MX9704105A (es) 1997-09-30
SK68597A3 (en) 1997-11-05
JPH10509729A (ja) 1998-09-22
FR2727629A1 (fr) 1996-06-07
MA23737A1 (fr) 1996-07-01
TR199501530A1 (tr) 1996-10-21
BR9509961A (pt) 1997-11-25
FI972383L (fi) 1997-06-05
AR002946A1 (es) 1998-05-27
WO1996017616A1 (fr) 1996-06-13
EP0797444A1 (fr) 1997-10-01
FR2727629B1 (enExample) 1997-02-28
NO972558D0 (no) 1997-06-05
FI972383A7 (fi) 1997-06-05

Similar Documents

Publication Publication Date Title
US20050026871A1 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
US20030158154A1 (en) Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
PT2133084E (pt) Formulação farmacêutica que compreende compostos de lantânio
JP2014205711A (ja) ビタミンｄ誘導体の前用量投与によってアレンドロネート等のビスフォスフォネートの生体利用効率を高める方法
US4861590A (en) Sustained release fluoride and calcium composition
WO2010008976A2 (en) Combined calcium, magnesium and vitamin d supplements
US20050214388A1 (en) Multivitamin formulations containing controlled-release magnesium
WO2010090614A1 (en) Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form
EP1768748B2 (en) Compositions comprising strontium and vitamin d and uses thereof
US4859467A (en) Sustained release fluoride composition
EP1021087A1 (en) Serotonin containing formulation for oral administration and method of use
KR101318067B1 (ko) 란탄 화합물을 이용한 만성 신장 질환 (ｃｋｄ) 치료 방법
US20170157001A1 (en) Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases
US5013728A (en) Composition for treating osteoporosis and hormonal imbalance
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
CN1168634A (zh) 用于骨质疏松症疗程的试剂盒
DE20321698U1 (de) Medikament zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin-D-Derivats
MXPA97004105A (en) Set for use in a therapeutic treatment cycle of osteoporo
JP2020029404A (ja) 腸溶性組成物及びその製造方法
HK1084338B (en) Pharmaceutical formulation comprising lanthanum compounds
MXPA99000265A (en) Dietetic supplements containing calcium citrate and carbonil iron

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication